Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Priority Technology Holdings, Inc.Priority Technology Holdings Reports 20.1% Revenue Growth, Net Income Turnaround in Q3 2024
STERIS plcSteris Reports 7.3% Revenue Growth, Net Income Increase in Q3 2024
PMV Pharmaceuticals, Inc.PMV Pharmaceuticals Reports Q3 Financial Results, Net Loss Improves Despite Increased R&D Expenses
iHeartMedia, Inc.iHeartMedia Reports Mixed Q3 2024 Results with Revenue Growth and Net Loss
Sunrise Realty Trust, Inc.Sunrise Realty Trust Reports Significant Financial Growth Following Spin-Off from Advanced Flower Capital Inc.
HilleVax, Inc.HilleVax Reports Decrease in Cash and Cash Equivalents, Net Loss in Q3 2024
MESA LABORATORIES INC /CO/Mesa Laboratories Reports 8.8% Revenue Growth, Turnaround in Operating Income and Net Income for Q3 and H1 2024
ACORN ENERGY, INC.Acorn Energy Reports 28% Revenue Growth, Turnaround in Operating Income and Net Income for Nine Months Ended September 30, 2024
VERACYTE, INC.Veracyte Reports 29% Revenue Growth, Net Income Turnaround in Q3 2024
Vanda Pharmaceuticals Inc.Vanda Pharmaceuticals Reports 23% Revenue Growth, Net Loss in Q3 2024
AMEDISYS INCAmedisys Reports Revenue Growth, Decline in Profitability in Latest Quarter
ImageneBio, Inc.Ikena Oncology Reports Significant Financial Changes, Decline in Cash and Cash Equivalents in Latest Quarter
RADIAN GROUP INCRadian Group Reports Mixed Q3 Results, Net Investment Income Drives Growth
NORTECH SYSTEMS INCNortech Systems Reports Decline in Net Sales and Gross Profit for Q3 and Nine Months of Fiscal 2024
Jazz Pharmaceuticals plcJazz Pharmaceuticals Reports 9% Revenue Growth in Q3 2024, Net Income Up 46%
Angel Oak Mortgage REIT, Inc.Angel Oak Mortgage REIT Reports Increased Net Income and Strong Liquidity in Q3 2024
Carisma Therapeutics Inc.Carisma Therapeutics Reports Significant Financial Decline, Uncertainty Over Future Funding
Cingulate Inc.Cingulate Inc. Reports Improved Financials, Reduced Losses in Latest Quarter
Walker & Dunlop, Inc.Walker & Dunlop Reports 9% Revenue Growth, 34% Increase in Net Income for Q3 2024
Thryv Holdings, Inc.Thryv Holdings Reports Decline in Revenue and Net Loss for Q3 and Nine Months of 2024
Vital Farms, Inc.Vital Farms Reports 31% Revenue Growth, Net Income Increase in Latest Quarter
SHENANDOAH TELECOMMUNICATIONS CO/VA/Shenandoah Telecommunications Reports Significant Financial Developments, Including 30% Revenue Growth and Net Loss in Latest Quarter
NCR VOYIX CorpNCR Voyix Reports 12% Revenue Decline, Net Income Turnaround in Q3 2024
Jasper Therapeutics, Inc.Jasper Therapeutics Reports Third Quarter Financial Results, Net Loss of $18.6 Million
Rapport Therapeutics, Inc.Rapport Therapeutics Reports Financial Results, Advances Lead Product Candidate RAP-219